newself semaglutide Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity NOVO-LELA – Revolutionary Approach to

Tirzepatide once weekly for obesity: results from the SURMOUNT-3 trial

It works by activating the GLP-1 receptor , a hormone involved in appetite regulation, which can help some people feel fuller and reduce hunger

Although often associated in slimming programs, fat burners and drainers do not act in the same way

Third, our projections did not account for the time-varying uptake and intensification of other cardioprotective therapies, including statins, ACE inhibitors, and SGLT2 inhibitors, which have become increasingly common in routine clinical practice and are known to reduce cardiovascular risk in high-risk adults with type 2 diabetes

If headaches persist and become more intense over time, it is highly recommended to get in touch with your healthcare provider